Growth Opportunities in the Western European IVD Industry, Forecast to 2021

  • ID: 4330377
  • Report
  • Region: Europe, Western Europe
  • 132 Pages
  • Frost & Sullivan
1 of 4
Increased R&D Investments and M&As Propel the Growth of Mobile POCT and Clinical Genomics Solutions

FEATURED COMPANIES

  • Abbott
  • Becton Dickinson
  • Danaher
  • Hologic
  • Meridian
  • Qiagen
  • MORE

Despite global economic and industry challenges, in-vitro diagnostics (IVD) markets continue to grow, mainly due to fast-growing segments like molecular diagnostics, point-of-care testing (POCT), and tissue diagnostics.. A few market dynamics are either positively or negatively affecting certain specific segments in the IVD space; for example, the self-monitoring blood glucose (SMBG) segment's growth in emerging markets is severely dampened by the slowing growth from reimbursement reductions in Western Europe.The broad applicability of POCT, combined with downward pricing trends enabled by microfluidics integration, supports the long-term growth of this segment. The Western European markets continue to drive molecular diagnostics segment growth rather than the emerging Eastern European markets.

The recent success of companion diagnostic tests and personalised medicine is driving the uptake of various tests in an aim to save costs, thus opening up an opportunity to expand the test menus in existing installs. Diagnostic testing will continue to move towards process simplicity and decentralisation. IVD market participants are expected to employ a diverse set of strategies rather than rely on comprehensive product portfolios to grow their businesses. Companies are also gaining new market access through acquisitions, and this has intensified competition among tier 1 participants.

This study offers comprehensive information on every aspect of the IVD market. It is segmented into 8 subdivisions, namely, immunochemistry, POCT, SMBG, molecular diagnostics, clinical microbiology, haemostasis, hematology, and tissue diagnostics. Discussion on key trends and opportunities and company profile analysis by segment are also provided. In addition, there are dedicated country chapters for the key Western European markets (Germany, France, the United Kingdom, Spain, Italy, Benelux, and Scandinavia) and a snapshot of the regulatory policies awaiting to transform the industry.

READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott
  • Becton Dickinson
  • Danaher
  • Hologic
  • Meridian
  • Qiagen
  • MORE

1. Executive Summary

  • Western European IVD Market Dynamics
  • Key Trends Driving the Market
  • Strategic Imperatives for IVD Companies
  • 8 Big Market Directions
  • Scope and Segmentation
  • Key Questions This Study Will Answer

2. Market Overview

  • Market Definition-Diagnostics for Health
  • IVD Value Chain across Patient Continuum
  • Segment Overview

3. Market Dynamics-Western Europe

  • How Do IVDs Reach Patients in Europe?
  • Major Regulatory Developments and Future Implications
  • Reimbursement Policies for IVD across Western Europe (EU5)
  • Stepping Stones that Promote IVD among the Public (with Government Backing)

4. Trend Analysis-Western European IVD Market

  • Key Trend 1-Consolidation of Labs
  • Key Trend 2-Decentralized Laboratory Testing

5. Emerging Technologies in the Western European IVD Market

  • Emerging Technology 1-Companion Diagnostics
  • Participants are Expanding Their Product Portfolios to Include Companion Diagnostics
  • Emerging Technology 2-Liquid Biopsy
  • Participants are Expanding Their Product Portfolios to Include Liquid Biopsy
  • Other Key Emerging Technologies

6. Regional Analysis-Western Europe

  • Regional Perspective
  • Market Analysis-Germany
  • Market Analysis-France
  • Market Analysis-Italy
  • Market Analysis-The United Kingdom
  • Market Analysis-Spain
  • Market Analysis-Benelux
  • Market Analysis-Scandinavia
  • Market Analysis-Rest of Europe
  • Market Analysis-Rest of Europe (Poland)

7. Drivers and Restraints-IVD Market

  • Market Drivers
  • Market Restraints

8. Growth Opportunities and Companies to Action

  • Growth Opportunity 1-Infectious Disease Diagnostics
  • Growth Opportunity 2-Data-driven Digital POCT
  • Growth Opportunity 3-Personalized Medicine through Companion Diagnostics and Pharmacogenomics
  • Growth Opportunity 4-Genetic Testing
  • Growth Opportunity 5-Geographical Expansion to Eastern Europe

9. Revenue Forecast-IVD Market

  • Western European IVD Market by Segment
  • Western European IVD Market by Country
  • Western European IVD Market by Market Participants
  • Key Mergers, Acquisitions, and Partnership Assessment
  • Western European IVD Market-Revenue Forecast

10. Segment Analysis-IVD Market

  • Western European IVD Market-Segment Life Cycle Analysis

11. Immunochemistry Segment Analysis

  • Segment Overview
  • Revenue Forecast
  • Snapshot of Key Participants
  • Market Share of Top Competitors
  • Key Trends
  • Growth Opportunities

12. Molecular Diagnostics Segment Analysis

  • Segment Overview
  • Revenue Forecast
  • Snapshot of Key Participants
  • Market Share of Top Competitors
  • Key Trends
  • Growth Opportunities

13. POCT Segment Analysis

  • Segment Overview
  • Revenue Forecast
  • Snapshot of Key Participants
  • Market Share of Top Competitors
  • Key Trends
  • Growth Opportunities

14. Tissue Diagnostics Segment Analysis

  • Segment Overview
  • Revenue Forecast
  • Snapshot of Key Participants
  • Market Share of Top Competitors
  • Key Trends
  • Growth Opportunities

15. Self-monitoring Blood Glucose Segment Analysis

  • Segment Overview
  • Revenue Forecast
  • Snapshot of Key Participants
  • Market Share of Top Competitors
  • Key Trends
  • Growth Opportunities

16. Clinical Microbiology Segment Analysis

  • Segment Overview
  • Revenue Forecast
  • Snapshot of Key Participants
  • Market Share of Top Competitors
  • Key Trends
  • Growth Opportunities

17. Haemostasis Segment Analysis

  • Segment Overview
  • Revenue Forecast
  • Snapshot of Key Participants
  • Market Share of Top Competitors
  • Key Trends
  • Growth Opportunities

18. Haematology Segment Analysis

  • Segment Overview
  • Revenue Forecast
  • Snapshot of Key Participants
  • Market Share of Top Competitors
  • Key Trends
  • Growth Opportunities

19. Conclusion

  • Top Predictions for the Western European IVD Market
  • Legal Disclaimer
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott
  • Affymetrix
  • Alere
  • Becton Dickinson
  • Biomerieux
  • Cephed
  • Danaher
  • Gen-Probe
  • Grifols
  • Hologic
  • Horiba
  • Illumina
  • Meridian
  • Orthoclinical Diagnostics
  • Perkin-Elmer
  • Qiagen
  • Roche
  • Siemens
  • Sysmex
  • Thermofisher Scientific
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll